Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05477485 · ClinicalTrials.gov registry record · NA
Antiretroviral Improvement Among Medicaid Enrollees
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05477485: Clinical Trial NA study, sponsored by Virginia Commonwealth University.
NCT05477485 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05477485, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.
Primary Outcome
HIV viral load data come from Virginia Department of Health (VDH) routine surveillance. Viral load data indicate whether or not an individual was virally suppressed, i.e., the level of HIV in a blood sample was less than the detectable limit.
Interventions
- BEHAVIORAL Experimental: AIMS program - patient
- OTHER No Intervention/Usual care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2023-04-27 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Why NCT05477485 stopped before completion
NCT05477485 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental: AIMS program - patient is the first listed.
NCT05477485 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05477485 about?
NCT05477485 is a clinical study titled "Antiretroviral Improvement Among Medicaid Enrollees". This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.
What is the current status of trial NCT05477485?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2023-04-27. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05477485?
The interventions under investigation include: Experimental: AIMS program - patient (BEHAVIORAL), No Intervention/Usual care (OTHER).
Who is sponsoring clinical trial NCT05477485?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05477485's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI